FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1514857936> ?p ?o ?g. }

• W1514857936 endingPage "57" @default.
• W1514857936 startingPage "57" @default.
• W1514857936 abstract "Worldwide, diabetes mellitus presents a high burden for individuals and society. In Latin America, many people with diabetes have limited access to health care, which means that indirect costs may exceed direct health care cost. Diabetes is Mexico's leading cause of death.To evaluate the cost-effectiveness ratios of the most used oral hypoglycemic agents (OHA) in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City.A cross-sectional and analytic study was conducted in Mexico City.Twenty-seven adult outpatients with type 2 diabetes who were treated either with metformin or glibenclamide were included. Acarbose was used as an alternative strategy. The study was carried out from the perspective of Mexican society. Direct medical and nonmedical costs as well as indirect costs were evaluated using a structured questionnaire. Efficacies of all drug treatments were evaluated retrospectively. A systematic search was conducted to select published randomized clinical trials based on predetermined inclusion criteria, and treatment success was defined as glycosylated hemoglobin factor ≤ 7%. Efficacy data of each drug and/or combination were analyzed using meta-analysis. The Monte Carlo Markov model was used. Quality-adjusted life-years (QALY) were used as the unit of effectiveness; incremental and sensitive analyses were performed and a 5% discount rate was calculated. A hypothetical cohort of 10,000 patients was modeled.The odds ratios of the success of each drug treatment were obtained from the meta-analyses, and were the following: 5.82 (glibenclamide), 3.86 (metformin), 3.5 (acarbose), and 6.76 (metformin-glibenclamide). The cost-effectiveness ratios found were US$272.63/QALY (glibenclamide), US$296.48/QALY (metformin), and US$409.86/QALY (acarbose). Sensitivity analysis did not show changes for the most cost-effective therapy when the effectiveness probabilities or treatment costs were modified.Glibenclamide is the most cost-effective treatment for the present study outpatient population diagnosed with type 2 diabetes in the early stages." @default.
• W1514857936 created "2016-06-24" @default.
• W1514857936 creator A5002179703 @default.
• W1514857936 creator A5038030775 @default.
• W1514857936 creator A5062979982 @default.
• W1514857936 creator A5065439469 @default.
• W1514857936 creator A5069982471 @default.
• W1514857936 creator A5079215983 @default.
• W1514857936 date "2012-03-01" @default.
• W1514857936 modified "2023-09-30" @default.
• W1514857936 title "Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City" @default.
• W1514857936 cites W1867945356 @default.
• W1514857936 cites W1893959718 @default.
• W1514857936 cites W1930639259 @default.
• W1514857936 cites W1995404454 @default.
• W1514857936 cites W1998281731 @default.
• W1514857936 cites W1999398484 @default.
• W1514857936 cites W2023432450 @default.
• W1514857936 cites W2036731511 @default.
• W1514857936 cites W2050722926 @default.
• W1514857936 cites W2074217384 @default.
• W1514857936 cites W2074471046 @default.
• W1514857936 cites W2129416530 @default.
• W1514857936 cites W2151921086 @default.
• W1514857936 cites W2153059725 @default.
• W1514857936 cites W2154440391 @default.
• W1514857936 cites W2159987975 @default.
• W1514857936 cites W2164383792 @default.
• W1514857936 cites W2324992560 @default.
• W1514857936 cites W608708520 @default.
• W1514857936 doi "https://doi.org/10.2147/ceor.s27826" @default.
• W1514857936 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3304331" @default.
• W1514857936 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22427724" @default.
• W1514857936 hasPublicationYear "2012" @default.
• W1514857936 type Work @default.
• W1514857936 sameAs 1514857936 @default.
• W1514857936 citedByCount "7" @default.
• W1514857936 countsByYear W15148579362014 @default.
• W1514857936 countsByYear W15148579362015 @default.
• W1514857936 countsByYear W15148579362017 @default.
• W1514857936 countsByYear W15148579362019 @default.
• W1514857936 countsByYear W15148579362022 @default.
• W1514857936 crossrefType "journal-article" @default.
• W1514857936 hasAuthorship W1514857936A5002179703 @default.
• W1514857936 hasAuthorship W1514857936A5038030775 @default.
• W1514857936 hasAuthorship W1514857936A5062979982 @default.
• W1514857936 hasAuthorship W1514857936A5065439469 @default.
• W1514857936 hasAuthorship W1514857936A5069982471 @default.
• W1514857936 hasAuthorship W1514857936A5079215983 @default.
• W1514857936 hasBestOaLocation W15148579361 @default.
• W1514857936 hasConcept C126322002 @default.
• W1514857936 hasConcept C134018914 @default.
• W1514857936 hasConcept C138816342 @default.
• W1514857936 hasConcept C156957248 @default.
• W1514857936 hasConcept C159110408 @default.
• W1514857936 hasConcept C187212893 @default.
• W1514857936 hasConcept C194828623 @default.
• W1514857936 hasConcept C2776617576 @default.
• W1514857936 hasConcept C2777180221 @default.
• W1514857936 hasConcept C2780323712 @default.
• W1514857936 hasConcept C2910068830 @default.
• W1514857936 hasConcept C512399662 @default.
• W1514857936 hasConcept C555293320 @default.
• W1514857936 hasConcept C71924100 @default.
• W1514857936 hasConcept C74909509 @default.
• W1514857936 hasConceptScore W1514857936C126322002 @default.
• W1514857936 hasConceptScore W1514857936C134018914 @default.
• W1514857936 hasConceptScore W1514857936C138816342 @default.
• W1514857936 hasConceptScore W1514857936C156957248 @default.
• W1514857936 hasConceptScore W1514857936C159110408 @default.
• W1514857936 hasConceptScore W1514857936C187212893 @default.
• W1514857936 hasConceptScore W1514857936C194828623 @default.
• W1514857936 hasConceptScore W1514857936C2776617576 @default.
• W1514857936 hasConceptScore W1514857936C2777180221 @default.
• W1514857936 hasConceptScore W1514857936C2780323712 @default.
• W1514857936 hasConceptScore W1514857936C2910068830 @default.
• W1514857936 hasConceptScore W1514857936C512399662 @default.
• W1514857936 hasConceptScore W1514857936C555293320 @default.
• W1514857936 hasConceptScore W1514857936C71924100 @default.
• W1514857936 hasConceptScore W1514857936C74909509 @default.
• W1514857936 hasLocation W15148579361 @default.
• W1514857936 hasLocation W15148579362 @default.
• W1514857936 hasLocation W15148579363 @default.
• W1514857936 hasLocation W15148579364 @default.
• W1514857936 hasOpenAccess W1514857936 @default.
• W1514857936 hasPrimaryLocation W15148579361 @default.
• W1514857936 hasRelatedWork W2003426849 @default.
• W1514857936 hasRelatedWork W2004651939 @default.
• W1514857936 hasRelatedWork W2152265658 @default.
• W1514857936 hasRelatedWork W2398612587 @default.
• W1514857936 hasRelatedWork W2784439604 @default.
• W1514857936 hasRelatedWork W3160499970 @default.
• W1514857936 hasRelatedWork W4200290715 @default.
• W1514857936 hasRelatedWork W4200596022 @default.
• W1514857936 hasRelatedWork W4213179410 @default.
• W1514857936 hasRelatedWork W2602828845 @default.
• W1514857936 isParatext "false" @default.
• W1514857936 isRetracted "false" @default.

• next